-
Dravet Syndrome Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies By Delveinsight
26 May 2025 13:26 GMT
… drug (IND) application for ETX101, allowing the company to initiate clinical trials … Pharmaceuticals, and others
Key Dravet Syndrome Therapies: TAK-935 (soticlestat), BELVIQ (lorcaserin … Syndrome treatment includes antiepileptic medications like stiripentol …
-
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
09 Jul 2025 12:45 GMT
… pharmaceutical and clinical experience spanning large pharma, biotech, therapeutics, medical … Crohn’s disease and lorcaserin for morbid obesity. … it will transform the treatment landscape. For more … studies and clinical trials conducted by the Company …
-
Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)
20 Feb 2025 22:50 GMT
… Drug Administration (FDA) is alerting the public that results from a clinical trial … about your medical treatment.
Lorcaserin is a prescription medicine approved by FDA in 2012 … XR).
When approving lorcaserin, we required the drug manufacturer, Eisai Inc …
-
Eisai Closes Door on Lorcaserin Program for Dravet Syndrome
02 Dec 2024 21:25 GMT
… discontinued 2 clinical trials for lorcaserin in Dravet syndrome … lorcaserin as an effective antiseizure treatment after other medications failed.
Issues with the trial … FDA-approved weight-loss drug. In February 2020, Eisai voluntarily withdrew the medication …
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 18:21 GMT
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 10:44 GMT
-
A Randomized Controlled Trial of Lorcaserin in Cocaine Use Disorder
07 Oct 2024 19:17 GMT
… US Food and Drug Administration-approved medications for the treatment of CUD, and … , placebo-controlled trial of lorcaserin in cocaine use disorder. Drug Alcohol Depend. 2024 … with lorcaserin – The FDA’s review of the CAMELLIA-TIMI 61 trial. N …
-
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
16 Oct 2024 13:20 GMT
… biotechnology company focused on developing novel drugs for the targeted treatment … Food and Drug Administration (FDA)- approved … pharmaceutical companies engaged in drug research and clinical trials, as well as medical … tests. Compared to Lorcaserin, BMB-101 …
-
Phentermine and other psychotropic drugs prescribed as ‘diet pills’
07 Oct 2024 05:43 GMT
… , about 402,000 pills of lorcaserin-based psychotropic drugs, which were approved in … U.S. Food and Drug Administration's (FDA) decision to stop … .
“Diet pills with ingredients, such as phentermine and phendimetrazine, are medical narcotics …
-
VHA Has Very Low Use of Antiobesity Drugs Despite High Percentages of Overweight Veterans
17 May 2024 05:01 GMT
… reports on use of drugs in veterans also have … with orlistat (-3.9%) and lorcaserin (-3.6%). “Comorbid obstructive … than previously available medications, is limited by medication shortages and … on standard Food and Drug Administration criteria for AOM …
About
© 1995-2025